



The establishment of a latent reservoir after infection by Human Immunodeficiency Virus 
type 1 (HIV-1) is a significant obstacle to an HIV cure. Antiretroviral therapies (ART) effectively 
target actively replicating virus, but are ineffective at targeting latently infected cells. Thus, an 
area of key interest lies in developing methods to induce expression of these latent proviruses. As 
such, an understanding of the molecular mechanisms which govern HIV transcription is of interest 
to identify new targets to mediate latency reversal. The aim of this research was to investigate the 
effect of transcriptional interference on HIV latency in cell models with characterized integration 
sites. In the model organism Saccharomyces cerevisiae (yeast), regulation of transcription involves 
a complex set of proteins that creates heterochromatin in regions after they have been transcribed 
to prevent cryptic transcription—transcription initiation in non-promoter regions. Evidence 
suggests this mechanism works in a similar capacity in humans, and we hypothesized this may 
contribute to HIV latency. Using CRISPR-Interference, we targeted a nuclease-deactivated Cas9 
protein (dCas9) fused to the KRAB transcriptional repression domain to promoter regions of 
known genes of HIV integration to silence host gene transcription and examine the role of 
transcriptional interference in HIV latency. Cell lines expressing dCas9-KRAB and both single 
and multiple gRNAs targeted to host gene promoters showed moderate to high reduction of mRNA 
expression of the host gene of HIV integration but did not fully ablate transcription. In these 
systems, we did not observe an altered response in latency reversal. If transcriptional interference 
does indeed have an effect on latency, then it appears that merely diminishing transcription is not 
sufficient to alter reactivation, or that transcriptional interference plays a minor overall role in 





 In the search for a cure for Human Immunodeficiency Virus (HIV), the rapid establishment 
of a latent reservoir of HIV-infected cells that cannot be targeted by traditional antiretroviral 
therapies (ART) remains a significant obstacle1. This latent pool is the source of plasma viral 
rebound upon cessation of ART. Numerous cellular mechanisms that contribute to latency have 
been characterized, including the sequestration of host transcription factors and the role of 
epigenetic modifications at the viral promoter2. Another proposed, but less characterized, 
mechanism is transcriptional interference. HIV preferentially integrates into intronic regions of 
actively transcribed genes3. It has been proposed that RNA Polymerase II (RNAPolII) initiation 
from the host gene promoter can collide with RNAPolII emanating from the provirus promoter (or 
LTR), resulting in transcriptional interference via steric hindrance that helps to maintain 
latency4.          
Interestingly, this mechanism may be more complex, as transcriptional regulation has been 
linked to chromatin regulation of gene bodies. Lysine methylation of histone H3 on lysine 36 
(H3K36me) has been implicated in the regulation of cryptic transcription, a phenomenon where 
RNA Polymerase II initiates transcription at non-promoter regions5. Extensively studied in yeast, 
deposition of H3K36me by transcribing RNAPolII recruits protein complexes that deacetylate 
methyl-marked nucleosomes5. This mechanism prevents random initiation of RNAPolII within 
gene bodies after the creation of heterochromatin has occurred post-transcription. In yeast, this 
pathway uses the non-essential enzyme Set2 that can perform all 3 methylation reactions required 
to create H3K36 tri-methylation (me3). The ortholog present in humans, SETD2,  interacts with 
RNAPolII, but it has been identified as an essential protein in humans5. In contrast to the system 
in yeast, SETD2 associates with heterogeneous nuclear ribonucleoprotein L (hnRNPL) for lysine 
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trimethylation; knockdown of hnRNPL expression results in a reduction of H3K36me5. The role 
of H3K36me in the maintenance of repressive chromatin during transcriptional elongation is 
similar in humans but may be independent of acetylation6. We are interested to determine if the 
H3K36me mechanism in yeast is similar in humans and if it may play a role in the maintenance of 
latency in HIV-infected cells. To examine this, guide RNAs targeted to the promoter of the host 
gene will be used to guide a defective Cas9 protein fused to the KRAB repression domain (dCas9-
KRAB) to the host gene promoter in a technique termed CRISPR Interference (CRISPRi)7. 
Binding of dCas9-KRAB will induce repressive chromatin at guide RNA target sites and repress 
transcription of the host gene. We anticipate this system will allow further insight into the role of 
transcriptional interference in HIV latency reversal and may identify novel targets for latency 




2D10 and E4 cells were a gift from Dr. Jonathan Karn (Case Western Reserve). Cells were 
maintained in RPMI1640 (LifeTech) supplemented with 10% FBS (Millipore) and 100U/mL 
Pen/Strep (LifeTech) at 37°C/5%CO2. 
The 2D10 cell model is a Jurkat T-cell line that contains an integrated HIV reporter 
carrying LTR driven expression of regulatory proteins Tat and Rev, as well as a destabilized green 
fluorescent protein (d2EGFP). The integration site of this LTR-GFP construct in 2D10 cells has 
been characterized and identified to be the MSRB1 gene. This line also carries an attenuated H13L 
mutation in Tat which helps promote a cell’s entrance into latency8. The E4 model was developed 
similarly to the 2D10 model, but E4 cells carry wild-type Tat and have an integration site in an 
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intron of the gene CD2AP9. In these models, HIV has an antisense orientation in 2D10 cells and a 
sense orientation in E4 cells  relative to the host gene10. 
Guide RNA design 
CRISPR gRNAs were targeted to the genes MSRB1 and CD2AP , the host gene of  HIV 
integration for 2D10 and E4 cells, respectively. The non-targeted gene of one model served as a 
control gene for the other model (e.g., CD2AP was used as a control gene in 2D10 cells). All 
gRNAs were designed using the CRISPR Design tool (Table 1)(http://crispr.mit.edu). The gRNAs 
were selected based on predicted binding efficiency, low potential for off-target binding and 
location upstream and downstream of the host gene transcription start site (Figure 1). Multiple 
candidate gRNAs for each gene were selected; these sequences and their anti-sense strands (Sense 
– S, Antisense – AS) were designed with BsmBI or BbsI endonuclease sites for single- or multi-
gRNA cloning, respectively. All gRNAs were created using the IDT Oligo Analyzer Tool 
(https://www.idtdna.com/calc/analyzer). The multi-gRNA cloning scheme was performed using 
the Golden Gate cloning method: the insertion of multiple DNA segments in one ligation 
reaction12. The vectors used for this cloning scheme—pLV hU6-sgRNA hUbC-dCas9-KRAB-
T2a-Puro, phH1-gRNA, pmU6-gRNA, phU6-gRNA and ph7SK-gRNA—were purchased from 
Addgene and gifted by Dr. Charles Gersbach (Duke University)(Addgene plasmid # 71236, 53186, 












Figure 1 – Schematic of proviral integration sites and gRNA targeting for MSRB1 and CD2AP –
Two gRNAs were targeted a short distance upstream of the transcriptional start site, and two 
gRNAs were targeted downstream. In cells with single-target systems, one gRNA was targeted 




Preparing gRNA oligonucleotides for Golden Gate11 Cloning 
In a 20µL reaction, stock of S/AS strands were added to a final concentration of 5 µM with 
T4 Polynucleotide Kinase (PNK) (NEB), 1x T4 PNK buffer (NEB), and 1mM ATP. The reaction 
was incubated at 37ºC for 1 hour, placed in a 95ºC heat block, and allowed to cool to 30ºC. 
Plasmid design for single- and multi-gRNA constructs 
Single–gRNA Constructs – The plasmid vector pLV hU6-sgRNA hUbC-dCas9-KRAB-
T2a-Puro was digested with BsmBI (NEB) and dephosphorylated with rSAP (NEB) with 1x Fast-
Digest buffer (ThermoFisher) and 0.1 mg/mL BSA (NEB) in a 30µL reaction. The digests were 
incubated at 37ºC for 2 hours. The digests were gel purified from a 1% agarose gel using a 
Molecular Biology GeneJET Gel Extraction Kit (ThermoFisher) using manufacturer specifications 
and eluted in 30µL 10mM Tris-HCl pH8.0. Guide RNA oligonucleotides were diluted 1:25 with 
water; 1µL diluted oligonucleotides, 30ng of gel purified plasmid, and T4 Ligase buffer (NEB) 
were added in a 10µL reaction with 0.1 mg/mL BSA and 1x T4 Ligase buffer. The reactions were 
incubated at room temperature for 30 minutes.  
Each ligation reaction was transformed into 50µL Stbl2 competent E. coli (Invitrogen) by 
being heat shocked at 42ºC for 45 seconds. After heat shock, 250µL of SOC media was added to 
each reaction and cells were incubated in a 37ºC, 225 rpm shaker for 1 hour. Cells were plated on 
LB/Agar/Carbenicillin plates and incubated overnight at 37ºC. Colonies from each plate were 
picked and grown up in LB/Carbenicillin cultures, and plasmid DNA was isolated with a QIAprep 
Spin Miniprep Kit (Qiagen) to the manufacturer specifications and eluted in 30µL 10mM Tris-
HCl pH8.0. 
Multi–gRNA Constructs – To incorporate all 4 plasmids into 1 vector, gRNAs were cloned 
using a protocol modified from the Golden Gate assembly outlined in Kabadi et. al.11. For this 
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multiplexed system, a pre-designed vector containing dCas9-KRAB was not available. Therefore, 
the hU6 promoter of pLV hU6-sgRNA hUbC-dCas9-KRAB-T2a-Puro was removed such that 
BsmBI restriction sites could be added to make the vector suitable for Golden Gate cloning. To 
remove the U6 region, the plasmid was digested with of PacI (NEB) and rSAP using the Fast-
Digest protocol previously outlined. The digested plasmid was gel purified from a 2% agarose gel 
with a Molecular Biology GeneJET Gel Extraction Kit (ThermoFisher) using manufacturer 
specifications and eluted in 30µL 10mM Tris-HCl pH8.0. The parent vector also needed BsmBI 
sites for the Golden Gate cloning scheme. Oligonucleotides containing BsmBI cut sites flanked 
with PacI cut sites were designed in the IDT analyzer tool (S5’-GATAAGAGACGTCTAGACGT 
CTCCACAAAT; AS5’-TTGTGGAGACGTCTAGACGTCTCTTATCAT). These annealed 
oligonucleotides were ligated into pLV hUbC-dCas9-KRAB-T2a-Puro with the same T4 ligation 
protocol previously outlined.  
Guide RNA S and AS strands were designed with BbsI (ThermoFisher) endonuclease sites. 
Combined gRNA oligonucleotides were made using the same T4 PNK protocol previously 
outlined. Each gRNA for MSRB1 and CD2AP was cloned into 1 of 4 plasmid vectors: ph7SK-
gRNA, pmU6-gRNA, phH1-gRNA, and phU6-gRNA. Each plasmid was digested with BbsI and 
rSAP using the Fast Digest protocol previously outlined. All digests were gel purified using a 
Qiaquick Gel Purification Kit (Qiagen) using manufacturer specifications and eluted in 30µL 
10mM Tris-HCl pH8.0. Guide RNA oligonucleotides were diluted and used in the ligation reaction 
previously outlined. Each ligation reaction was transformed into 50µL Top10 competent E. coli 
(Invitrogen) with the same heat shock and 37ºC incubation protocol. Cells were plated on 
LB/Agar/Kanamycin plates and incubated overnight at 37ºC. Colonies from each plate were 
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picked and grown up in LB/Kanamycin cultures, and DNA was isolated with a QIAprep Spin 
Miniprep Kit.  
Each of the gRNA plasmids were digested with BsmBI and run on a 1% agarose. The 
excised gRNA-containing segments were combined and gel purified into a one-pot mix of all 
excised segments using a Qiaquick Gel Purification Kit. A 2:1 ratio of one-pot gRNAs : pLV 
hUbC-dCas9-KRAB-T2a-Puro was used in the Golden Gate ligation protocol outlined in Kabadi 
et. al.8. Control gRNA vectors were made by adding an RNAPolIII polyA signal prior to the to the 
CRISPR gRNA sequence to prematurely terminate gRNA transcription while still expressing 
dCas9-KRAB within these lines. 
Each ligation reaction was transformed into 50µL SURE competent E. coli (Agilent), heat-
shocked, and incubated with the same procedure previously outlined. The cells were plated and 
grown up with LB/Carbenicillin, and plasmid DNA was isolated with the same protocol as 
previously outlined. 
Lentivirus generation and transduction 
293T cells were plated at 500,000 cells/well in a 6-well plate in RPMI (Gibco) 
supplemented with tetracycline-free (tet-free) FBS (Omega Scientific) and Pen/Strep 
(100U/mL:100ug/mL)(Gibco). 293T cells were transfected with the following to generate 
lentiviral particles: 0.5µg lentiviral plasmid vector, 4.6µL Mission Lentiviral Packaging Mix 
(Sigma-Aldrich), 2.7µL Fugene HD (Promega), and 30.3µL Opti-MEM (ThermoFisher). 48 hours 
after transfection, supernatant from each well was collected and filtered with a 0.45µm filter 
(Millipore) and 0.5mL aliquots of lentivirus were stored at -80ºC. 
2D10 and E4 cells were plated at 30,000 cells/well in a 96-well plate in 50µL of tet-free 
RPMI.  Cells were transduced with 50µL vector in the presence of polybrene at a final 
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concentration of 6µg/mL. The media was changed after 24 hours and replaced with tet-free RPMI 
supplemented with 500 ng/mL puromycin. The cells were maintained under puromycin to maintain 
dCas9-KRAB/gRNA lentiviral expression and cells were expanded for experiments. 
RNA Isolation and quantitative Real-Time PCR 
RNA was isolated from 2D10 cells using an RNeasy Mini Kit (Qiagen), including an on-
column DNase digestion in the RNA isolation, using the manufacturer specifications. RNA was 
reverse-transcribed into cDNA using a Maxima cDNA synthesis kit. Gene expression was assayed 
by qRT-PCR using FastStart Universal SYBR Green Master (Roche) on the QuantStudio 5 
(Applied Biosystems) with the primer sets in Table 2.  
Table 2 – RT-qPCR Primer sets — Forward and reverse primers shown 
 
10-fold serial dilutions of 2D10 cDNA was used to determine primer efficiency and relative 
expression of GFP to control genes TATA-binding protein (TBP) and β-actin using the Pfaffl 
method13. Two biological replicates of each cell population using a different targeting gRNA was 
used, and each biological replicate was plated in triplicate. 
Latency Reversal and Flow Cytometry 
Cells were plated in 96-well plates at 25,000 cells/well and treated with 250nM SAHA or 
10ng/mL TNFα for 24 hours. Cells were stained with LIVE/DEAD Fixable Aqua Dead Cell Stain 
(ThermoFisher) for 30 minutes, followed by a DPBS wash and fixation in 1.5% paraformaldehyde/ 
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DPBS. Cells were assayed by flow cytometry using the iQue Screener Plus (Intellicyt) and GFP 




Figure 2 - Flow cytometry gating scheme– 2D10 cells were gated (A), doublets excluded (B), and 
dead cells excluded via live/dead stain (C) prior to gating for GFP expression (D). E4 cells were 








In the course of this project, gRNAs targeted to the host genes of HIV integration in 2D10 
and E4 cells were cloned into lentiviral vectors co-expressing dCas9-KRAB—targeting the host 
gene for transcriptional repression. Both cell lines are Jurkat-derived models of HIV latency which 
contain an integrated proviral reporter which expresses GFP upon latency reactivation9. Each gene 
of integration was selected as a control gene because it was the integration site in another Jurkat 
model. It was hypothesized that altering host gene expression would alter the reactivation profiles 
in these models if transcriptional interference plays a role in maintenance of HIV latency. We first 
used an all-in-one CRISPRi system which expressed a single gRNA and dCas9-KRAB within the 
same construct and assed if this could effectively reduce target gene expression. We generated 
lentiviral vectors, transduced 2D10 and E4 cells, and puromycin selected to generate stable cell 
lines. After stable populations were established, we assayed MSRB1 and CD2AP gene expression 
via reverse-transcription/quantitative real-time PCR (RT-qPCR) to determine the level of 
CRISPRi-induced knockdown (Figure 3).  
In the real-time PCR analysis of the single-gRNA system used in 2D10 cells, mRNA 
expression was reported relative to β-Actin and TBP reference genes. These values were then 
standardized to a 2D10 control that did not contain dCas9-KRAB. As shown in Figure 3, mRNA 
expression was reduced in genes that were targeted, and no significant change was seen in genes 
that were not targeted. We observed a 50% reduction of MSRB1 expression in the MSRB1-1 
gRNA transduced cells, but saw a more sizable reduction, a 95% decrease, in cells harboring the 
MSRB1-2 gRNA. The reduction of CD2AP mRNA expression by both CD2AP-1 gRNA and 
CD2AP-2 gRNAs were comparable, demonstrating an approximate 65-75% reduction (Figure 3). 
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Encouraged by our RNA results demonstrating significant knockdown of targeted gene 
transcription, our established CRISPRi cell lines were then treated with two characterized latency 
reversing agents (LRAs) to examine the impact of targeting host gene expression on latency 
reversal. We treated our dCas9/KRAB/gRNA cell lines with various previously characterized 
LRAs including the HDAC inhibitor SAHA and TNFα, a cytokine which induces the NF-κB 
pathway. We then analyzed the level of latency reactivation to these LRAs via flow cytometry for 
GFP expression and excluded dead or dying cells via staining with a live/dead stain. Cell 
populations containing dCas9-KRAB single gRNAs targeted to either MSRB1 or CD2AP showed 
no significant difference in reactivation profiles when compared to normal 2D10 cells when 
reactivated with the HDAC inhibitor SAHA. When the same populations were reactivated with 
TNFα, cells with dCas9-KRAB+gRNA targeted to both MSRB1 and CD2AP showed a 9% 
increase in GFP expression when compared to the control 2D10 cells harboring no dCas9/gRNA 
expression cassette (Figure 4). However, there was no significant difference found when 
comparing GFP expression between MSRB1 or CD2AP gRNA populations, and as 2D10 cells do 
not harbor integrated virus in the CD2AP gene, this suggested this effect may be the result of 





Figure 3– Analysis of MSRB1 and CD2AP Gene Expression in 2D10 cells with Single gRNAs – 
mRNA expression of MSRB1 and CD2AP was performed by RT-qPCR. (A)  MSRB1 gene 
expression was reduced over 90% by MSRB1-2 gRNA, whereas the MSRB1-1 gRNA was less 
effective. (B) Both CD2AP-1 and -2 gRNAs show an similar reduction in CD2AP gene expression. 
Statistical analysis (T-Test with Dunn’s Multiple Comparison Correction) confirmed no 
significant difference in mRNA expression of non-targeted genes of normal and transduced 2D10 




Figure 4 – GFP Induction in Single-gRNA Constructs Upon Treatment with LRAs – 2D10 cell 
lines containing one gRNA with dCas9/KRAB were treated with 250nM SAHA or 10ng/mL TNFα 
and assayed for GFP expression via flow cytometry. Statistical analysis was performed comparing 
the different populations and no significant difference was detected in GFP expression between 
populations.  Error bars represent biological replicates. 
 
 While our single gRNA system achieved knockdown of host gene transcription, we looked 
to improve the level of targeting in an attempt to completely ablate gene transcription. To this end, 
we next used a more advanced CRISRPi system which expressed 4 independent gRNAs which 
could be used to increase overall targeting of the host gene11. Here we created multi-gRNA 
lentiviral vectors which were used to generate both 2D10 and E4 stable cell lines. In the analysis 
of the multi-gRNA system used in 2D10 and E4 cells, mRNA expression was reported relative to 
TBP expression, and these values were standardized to 2D10 and E4 populations containing 
dCas9-KRAB and terminating gRNA sequences (term 4gRNA). Those populations acted as more 
appropriate controls for the multi-gRNA-transduced cells because they contained vectors with 
dCas9/KRAB but could not target dCas9 to host genes due to lack of gRNA expression. 2D10 
Winecoff 
 15 
lines were generated first and thus expression of mRNA was assayed at multiple time points. E4 
lines were developed later and as such are still in development with limited data. As shown in 
Figure 5, MSRB1 mRNA expression in both 2D10 and E4 cells with four gRNAs experienced 
approximately 66% reduction initially, which reduced to 50% reduction at a second time point. 
Conversely, CD2AP expression was reduced by 75% with high variation in biological replicates, 
which improved to approximately 83% with low variation at a second time point. Using T-tests 
with multiple comparisons, it was determined that there was no significant change in GFP 
expression in these lines upon host transcription knockdown. While there appears to be an increase 
in GFP mRNA expression in the E4 lines, it is not significant when compared to the MSRB1 
gRNA containing E4 cells, suggesting an effect of gRNA/CRISPRi targeting (Figure 5). Further, 
we have observed that E4 reporter lines show increased GFP expression during initial puromycin 
selection which returns to basal levels after an extended amount of time under selection. 
Considering both of those points, it is likely that E4 GFP expression shown is a result of puromycin 
selection as opposed to gRNA targeting, and that GFP expression in E4 cells will decrease over 
time to a level similar to that shown in other figures. 
Latency reversal in response to the LRAs SAHA and TNFα in reporters with multiple 
gRNAs proved to be similar to populations with single-gRNA constructs (Figure 6). E4 cells at 
the 25 day timepoint show what appears to be significant differences in latency reactivation 
compared to control populations, but when comparing treated versus untreated populations in that 
figure, one can see that populations are amplified at proportional levels. Between-population T-




Figure 5 – Analysis of MSRB1 and CD2AP Gene Expression in cells with multi-gRNA targeting – 
mRNA expression of MSRB1 and CD2AP was performed by RT-qPCR. (A)  MSRB1 gene 
expression was reduced by 66% at 16 days and 50% at 45 days in 2D10 cells. (B) CD2AP 
expression decreased with less variance in biological replicates from day 16 to 45. (C) One E4 
biological replicate with a CD2AP 4gRNA construct was showing unusual expression levels 
compared to other replicates that was not representative of typical reduction levels observed in 
these experiments and was excluded from analysis. Statistical analysis confirmed no significant 
difference in mRNA expression of non-targeted genes compared to cell populations that did not 






Figure 6 – GFP Induction in Multi-gRNA Constructs Upon Treatment with LRAs – (A) 2D10 and 
(B) E4 cells containing multi-gRNA constructs were treated with 250nM SAHA or 0.1 ng/mL 
TNFα. More-recent replicates of 2D10 and E4 cells with multi-gRNA constructs (2D10 day 18, 
E4 day 18) were created and assayed as well. Statistical analysis was performed comparing the 
different populations and no significant difference was detected in GFP expression between 
populations.  Error bars represent biological replicates. 
 
Discussion 
The results demonstrate reducing the transcriptional activity of MSRB1 in 2D10 cells or 
CD2AP in E4 cells did not alter the level of latency reversal in either HIV latency model for both 
single- and multi-gRNA targeting. Real-time PCR data for single-gRNA targeting shows that the 
MSRB1-2 gRNA targeted to MSRB1 was very effective at reducing mRNA expression compared 
to moderate reduction by MSRB1-1 but increased targeting by the 4gRNA construct did not 
improve transcriptional knockdown. Inversely, the CD2AP 4gRNA construct was much more 
effective at reducing transcription compared single gRNAs. However, comparison of flow 





an effect on maintenance of HIV latency. This may indicate that the transcriptional interference 
may play a significantly lesser role in the maintenance of HIV latency.   
While we identified a highly effective MSRB1-targeted gRNA (MSRB1-2 gRNA) which 
initially reduced MSRB1 mRNA expression by approximately 95%, transcription was not 
completely ablated. To date, there is no literature on the level of transcription required to result in 
transcriptional interference of the HIV provirus. The use of a multiplex gRNA vector was 
employed in an attempt to entirely ablate transcription, as it was hypothesized that multiple targets 
of promoter regions would be more effective than a single target. However, while the CD2AP 
multiplex construct further decreased transcription of CD2AP, the MSRB1 construct decreased 
transcription at levels comparable to or worse than its single-gRNA counterpart for MSRB1. 
Additionally, neither construct completely ablated transcription for either gene. The utility of these 
genes in cell function was not assessed prior to the outset of this project. It is possible that these 
gene products are necessary for cell function, so there may be cellular mechanisms that are 
preventing complete ablation of transcription. The possibility remains that an impact on latency 
reversal will only be seen when transcription is entirely prevented—not merely reduced. Further 
work should clarify whether these genes are necessary for cell function and seek out other HIV 
latency models with known integration sites where such genes may not be vital for cell function. 
Future work with our current models will involve the use of chromatin 
immunoprecipitation assays to confirm H3K9 methylation presence in targeted promoter regions, 
and to examine H3K9 methylation levels as a result of multiplex gRNA targeted relative to single 
gRNA targeting. Current populations will be kept under puromycin selection and assayed to 
evaluate whether mRNA expression or GFP induction changes over time. However, if future 
efforts manage to completely prevent transcription in these models or others and there is still no 
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change in the latency reversal response, then transcriptional interference mechanisms may indeed 
be insignificant in the maintenance of HIV latency. As the role of transcriptional interference in 
HIV latency has never been truly examined in this context, this may lead a change in the current 
thinking regarding the molecular mechanisms which govern HIV latency. 
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